BESPOKE Study of ctDNA Guided Immunotherapy

Clinical trial NCT04761783 · COMPLETED

Trial details

NCT number: NCT04761783
Sponsor: Natera, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Colorectal Cancer Melanoma Non-small Cell Lung Cancer

Start date: 2021-05-28
Primary completion: 2023-12-31
Enrollment: 290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.